RecruitingNCT04292574

UK SMA Patient Registry

Spinal Muscular Atrophy Patient Registry of the United Kingdom and Ireland


Sponsor

Newcastle University

Enrollment

800 participants

Start Date

Jul 13, 2008

Study Type

OBSERVATIONAL

Conditions

Summary

Spinal muscular atrophy (SMA) is a form of motor neuron disease, most commonly caused by a mutation in the survival motor neuron 1 gene (SMN1) which results in a wide disease spectrum affecting children and adults. It is an autosomal recessive disorder and is therefore caused by inheritance of a mutated gene from each parent. All forms of SMA have an estimated combined incidence of 1 in 6,000 to 1 in 10,000 live births, with a carrier frequency of 1/40 to 1/60. The patient registry aims to facilitate a questionnaire-based research study in order to better characterise and understand the disease in the UK and in Ireland. Entry is via self-registration over a secure internet connection (https://www.sma-registry.org.uk/). Online, patients are asked to read an information sheet about the research project and then indicate their consent to demonstrate willingness to participate. Following online consent, subjects will be entered into the registry. This is an on-going database and all participants are invited to update their information on a biannual basis.


Eligibility

Inclusion Criteria1

  • All patients with a confirmed SMA diagnosis (or pending diagnosis) are eligible for inclusion. Diagnosis will be confirmed via genetic testing results

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient Registry

Participants who have volunteered to participate will complete various questionnaires relating to their conditions.


Locations(1)

John Walton Muscular Dystrophy Research Centre

Newcastle upon Tyne, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04292574


Related Trials